RDY · Dr Reddys Laboratories Ltd · Documents

$14.26 +0.11 (+0.74%) Q2 2026 earnings call transcript

Market Cap

$11.73B

833.07M

Volume · Oct 29 169.46K Avg daily vol (3M) 2.92M

The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.

Type	AI summary	Filing Date	Period
6-K	—	2023-05-22	—
6-K	—	2023-05-16	2023-05-15
6-K	—	2023-05-15	2023-05-12
6-K	—	2023-05-12	2023-05-11
6-K	—	2023-05-10	—
6-K	—	2023-05-10	—
6-K	—	2023-05-05	—
6-K	—	2023-04-24	2023-04-22
6-K	—	2023-04-21	—
6-K	—	2023-04-07	—
6-K	—	2023-03-24	2023-03-23
6-K	—	2023-03-24	2023-03-23
6-K	—	2023-03-21	2023-03-20
6-K	—	2023-03-16	—
6-K	—	2023-03-13	—
6-K	—	2023-02-28	—
6-K	—	2023-02-27	—
6-K	—	2023-02-17	2023-02-16
6-K	—	2023-02-09	2023-02-08
6-K	—	2023-02-03	—
6-K	—	2023-01-30	—
6-K	—	2023-01-27	—
6-K	—	2023-01-27	2023-01-26
6-K	—	2023-01-26	—
6-K	—	2023-01-25	—
6-K	—	2023-01-25	—
6-K	—	2023-01-25	—
6-K	—	2023-01-20	—
6-K	—	2023-01-13	2023-01-12
6-K	—	2023-01-13	—
6-K	—	2023-01-06	—
6-K	—	2022-12-29	—
6-K	—	2022-12-27	—
6-K	—	2022-12-27	—
6-K	—	2022-12-19	2022-12-17
6-K	—	2022-12-19	—
6-K	—	2022-12-16	—
6-K	—	2022-12-07	2022-12-06
6-K	—	2022-11-28	2022-11-24
6-K	—	2022-11-22	—
6-K	—	2022-11-16	—
6-K	—	2022-11-03	—
6-K	—	2022-11-02	2022-11-01
6-K	—	2022-10-31	—
6-K	—	2022-10-31	2022-10-29
6-K	—	2022-10-28	2022-09-30
6-K	—	2022-10-28	—
6-K	—	2022-10-24	2022-10-21
6-K	—	2022-10-13	—
6-K	—	2022-10-11	—

Showing 451–500 of 746 filings

Key facts CIK 1135951 CUSIP 256135203 13F (30d) 59 filings 54 filers Visit website Investor relations